Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of RNA

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

SN1 Reaction: Stereochemistry

S_N1 Reaction: Stereochemistry

This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...

Types of Hormones

Types of Hormones

Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.

SN1 Reaction: Kinetics

S_N1 Reaction: Kinetics

In an SN2 reaction, the reaction rate depends on both the type of nucleophile and the substrate. A hindered tertiary alkyl halide is practically inert to the SN2 mechanism despite using a strong nucleophile.
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...

SN1 Reaction: Mechanism

S_N1 Reaction: Mechanism

Kinetic studies of ionization of a tertiary halide in a protic solvent suggest that only the substrate participates in the rate-determining step (slow step). The nucleophile is involved only after the slowest step. The SN1 reaction takes place in a multiple-step mechanism.
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...

Acidity of 1-Alkynes

Acidity of 1-Alkynes

The acidic strength of hydrocarbons follows the order: Alkynes > Alkenes > Alkanes. The strength of an acid is commonly expressed in units of pKa — the lower the pKa, the stronger the acid. Among the hydrocarbons, terminal alkynes have lower pKa values and are, therefore, more acidic. For example, the pKa values for ethane, ethene, and acetylene are 51, 44, and 25, respectively, as shown here.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The hidden burden of kidney damage in chylomicronemia syndromes.

Atherosclerosis·2026

Same author

Clinical and biochemical characterization of a patient with prolidase deficiency, a rare disorder of collagen metabolism.

Molecular genetics and metabolism reports·2025

Same author

Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency.

Orphanet journal of rare diseases·2025

Same author

C4OH-carnitine: an important marker of ketosis in patients with and without inborn errors of metabolism.

Molecular genetics and metabolism·2025

Same author

Pathophysiology and therapies of CKD-associated secondary hyperparathyroidism.

Clinical kidney journal·2025

Same author

The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?

Atherosclerosis·2025

Search research articles

Related Experiment Video

Updated: Feb 7, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

Glutaric acidemia type 1.

Gary L Hedlund¹, Nicola Longo, Marzia Pasquali

¹Radiology, University of Utah, 2C412 SOM, 50 North Medical Drive, Salt Lake City, UT, USA.

American Journal of Medical Genetics. Part C, Seminars in Medical Genetics

|April 8, 2006

Summary

This summary is machine-generated.

Glutaric acidemia type 1 (GA-1) is a genetic disorder affecting amino acid metabolism. Early diagnosis via newborn screening and prompt treatment, including diet and carnitine therapy, can prevent severe neurological complications.

More Related Videos

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Experiment Videos

Last Updated: Feb 7, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Area of Science:

Biochemistry
Genetics
Metabolic Disorders

Background:

Glutaric acidemias are a group of inherited metabolic disorders characterized by increased urinary excretion of glutaric acid.
Glutaric acidemia type 1 (GA-1) specifically results from a deficiency in glutaryl-CoA dehydrogenase, impacting lysine, hydroxylysine, and tryptophan metabolism.
This deficiency leads to the accumulation of toxic metabolites, primarily 3-hydroxyglutaric and glutaric acid.

Purpose of the Study:

To summarize the key aspects of Glutaric Acidemia Type 1 (GA-1).
To highlight the clinical presentation, diagnostic methods, and therapeutic strategies for GA-1.
To emphasize the importance of early detection and intervention in managing GA-1.

Main Methods:

Review of literature on Glutaric Acidemia Type 1.
Analysis of diagnostic markers including newborn screening (elevated glutaryl carnitine - C5DC), urine organic acid analysis (excess 3-OH-glutaric acid), and urine acylcarnitine profiling.
Description of current therapeutic approaches.

Main Results:

GA-1 presents with potential neurological damage, including brain atrophy and acute dystonia, often triggered by childhood infections.
Diagnostic confirmation relies on elevated glutaryl carnitine on newborn screening and specific organic acid and acylcarnitine profiles in urine.
Effective management involves dietary restrictions, carnitine supplementation, and prompt treatment of infections.

Conclusions:

Early diagnosis of GA-1 through newborn screening is crucial.
Timely and appropriate therapy, including dietary management and carnitine supplementation, significantly reduces the risk of severe neurological sequelae like acute dystonia.
Comprehensive management strategies are essential for improving outcomes in patients with GA-1.